EG1216X

N/A

Report date: 2024/11/05 17:57:59

Base Information

Drug NameEG1216X

Drug Alias NameEG1216XEG-1216X

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnti-CD38

TargetsLymphocyte differentiation antigen CD38

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEirgenix Inc

China Registration ClassN/A

Active CompaniesEirgenix Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A